We are live on ! Find out more
APC

Aspire Private Capital Portfolio holdings

AUM $484M
1-Year Est. Return 17.28%
This Fund
S&P 500
This Quarter Est. Return
-5.82%
1 Year Est. Return
+17.28%
3 Year Est. Return
+49.56%
5 Year Est. Return
+43.58%
10 Year Est. Return
AUM
$263M
AUM Growth
-$17.3M
Cap. Flow
-$425K
Cap. Flow %
-0.16%
Top 10 Hldgs %
44.18%
Holding
709
New
42
Increased
114
Reduced
196
Closed
33
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQRX
601
DELISTED
EQRx, Inc. Common Stock
EQRX
$1K ﹤0.01%
200
A icon
602
Agilent Technologies
A
$39.9B
-12
Closed -$1K
ACB
603
Aurora Cannabis
ACB
$185M
$0 ﹤0.01%
6
ADNT icon
604
Adient
ADNT
$1.48B
$0 ﹤0.01%
8
AVX
605
Avax One Technology Ltd
AVX
$23.7M
0
AIG icon
606
American International
AIG
$42.4B
$0 ﹤0.01%
2
AMCX icon
607
AMC Global Media
AMCX
$490M
$0 ﹤0.01%
6
ASIX icon
608
AdvanSix
ASIX
$543M
$0 ﹤0.01%
9
ATER icon
609
Aterian
ATER
$5.02M
$0 ﹤0.01%
17
AUR icon
610
Aurora
AUR
$13.3B
$0 ﹤0.01%
56
AYTU icon
611
AYTU BioPharma
AYTU
$25M
0
BCML icon
612
BayCom
BCML
$335M
$0 ﹤0.01%
20
BDTX icon
613
Black Diamond Therapeutics
BDTX
$110M
-200
Closed
BSX icon
614
Boston Scientific
BSX
$71.4B
-53
Closed -$2K
BTAI icon
615
BioXcel Therapeutics
BTAI
$25.6M
-6
Closed -$1K
CHRW icon
616
C.H. Robinson
CHRW
$17.1B
$0 ﹤0.01%
2
CMP icon
617
Compass Minerals
CMP
$1.08B
-1
Closed -$38
CPRX
618
DELISTED
Catalyst Pharmaceutical
CPRX
$0 ﹤0.01%
+20
New +$237
CTXR icon
619
Citius Pharmaceuticals
CTXR
$17.6M
$0 ﹤0.01%
12
DKS icon
620
Dick's Sporting Goods
DKS
$17.8B
$0 ﹤0.01%
3
DNOW icon
621
DNOW Inc
DNOW
$2.81B
$0 ﹤0.01%
25
DOX icon
622
Amdocs
DOX
$6.28B
-7
Closed -$1K
DRLL icon
623
Strive US Energy ETF
DRLL
$286M
$0 ﹤0.01%
+15
New +$401
EDIT icon
624
Editas Medicine
EDIT
$445M
-50
Closed -$1K
EMXC icon
625
iShares MSCI Emerging Markets ex China ETF
EMXC
$23.9B
-397
Closed -$19K

Similar funds

Aspire Private Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Aspire Private Capital held 709 positions worth $263M, down 6.2% from $280M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Aspire Private Capital's Q3 2022 filing shows 42 new, 114 increased, 196 reduced and 33 closed positions. Its largest new stake was McKesson: 1,804 shares worth $613K. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.29M.

By sector, the portfolio is most concentrated in Technology at 4% of assets, up from 3.9% a quarter earlier, followed by Industrials and Healthcare.

  • Aspire Private Capital's largest Q3 2022 buy was McKesson: 1,804 shares worth $613K.
  • Aspire Private Capital added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q3 2022, an estimated $5.38M increase.
  • Aspire Private Capital's biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.29M.
  • Aspire Private Capital fully exited iShares MSCI Emerging Markets ex China ETF in Q3 2022, selling an estimated $19K.
  • Aspire Private Capital's ten largest holdings make up 44% of its $263M portfolio in Q3 2022.
  • Aspire Private Capital opened 42 new positions and closed 33 in Q3 2022.
  • Aspire Private Capital's portfolio value fell 6.2% quarter-over-quarter to $263M.

Based on Aspire Private Capital's 13F filing for Q3 2022, filed 10 Nov 2022.